$16.07
-0.12-0.74%
At close: -
$16.07
0.000.00%
After Hours: Jan 17, 4:01 PM EDT
Comments
Loading...
Anika Therapeutics (ANIK) Forecast
NewsEarningsAnika Therapeutics (ANIK) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAnika Therapeutics (NASDAQ:ANIK) Stock Quotes, Forecast and News Summary
Anika Therapeutics Stock (NASDAQ: ANIK) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Anika Therapeutics (ANIK) stock?
You can purchase shares of Anika Therapeutics (NASDAQ:ANIK) through any online brokerage.
Who are Anika Therapeutics (ANIK) competitors?
Other companies in Anika Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Sangamo Therapeutics (NASDAQ:SGMO) and Eledon Pharma (NASDAQ:ELDN).
What is the forecast, or price target, for Anika Therapeutics (ANIK) stock?
Anika Therapeutics has a consensus price target of $24.50.
What is the current price for Anika Therapeutics (ANIK)?
The stock price for Anika Therapeutics (NASDAQ: ANIK) is $16.07 last updated January 17, 2025 at 4:01 PM EST.
Does Anika Therapeutics (ANIK) pay a dividend?
There are no upcoming dividends for Anika Therapeutics.
When is Anika Therapeutics (NASDAQ:ANIK) reporting earnings?
Anika Therapeutics’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
Is Anika Therapeutics (ANIK) going to split?
There is no upcoming split for Anika Therapeutics.
What sector and industry does Anika Therapeutics (ANIK) operate in?
Anika Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.